No Data
12 Health Care Stocks Moving In Wednesday's Intraday Session
Sage Therapeutics Price Target Cut to $8.00/Share From $9.00 by Oppenheimer
Sage Therapeutics Is Maintained at Perform by Oppenheimer
Sage Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 EPS Results. Additionally, HC Wainwright & Co. Cut Its Price Target on the Stock From $25 to $14.
BofA Securities Maintains Sage Therapeutics(SAGE.US) With Sell Rating
HC Wainwright & Co. Maintains Neutral on Sage Therapeutics, Lowers Price Target to $14